Drug Shortage Report for BALMINIL DM (3MG/ML SUCROSE FREE)
Report ID | 195560 |
Drug Identification Number | 01928775 |
Brand name | BALMINIL DM (3MG/ML SUCROSE FREE) |
Common or Proper name | BALMINIL DM (3MG/ML SUCROSE FREE) |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROMETHORPHAN HYDROBROMIDE |
Strength(s) | 15MG |
Dosage form(s) | SYRUP |
Route of administration | ORAL ORAL |
Packaging size | 250ML |
ATC code | R05DA |
ATC description | COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-06-19 |
Estimated end date | 2024-02-28 |
Actual end date | 2023-10-03 |
Shortage status | Resolved |
Updated date | 2023-10-04 |
Company comments | OTC not reported on DS |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2023-10-04 | English | Compare |
v14 | 2023-10-03 | French | Compare |
v13 | 2023-10-03 | English | Compare |
v12 | 2023-10-03 | English | Compare |
v11 | 2023-08-17 | French | Compare |
v10 | 2023-08-17 | English | Compare |
v9 | 2023-07-20 | French | Compare |
v8 | 2023-07-20 | English | Compare |
v7 | 2023-07-17 | French | Compare |
v6 | 2023-07-17 | English | Compare |
v5 | 2023-07-04 | French | Compare |
v4 | 2023-07-04 | English | Compare |
v3 | 2023-06-20 | English | Compare |
v2 | 2023-06-19 | French | Compare |
v1 | 2023-06-19 | English | Compare |
Showing 1 to 15 of 15